A slight tangent: I don't buy the idea that the company does not know what the lines for the FDA will look like. I suspect they've had these constructed for many months now. It would be irresponsible for mgmt to make a comitment to foreign basing without costing it all out first.
If the lines were going to be no problem, mgmt would be publishing them right now as a tool to sway the vote. They are however, holding back because I think they know it'll be one more thing we will find wrong with the LOA.